SAN FRANCISCO (PRWEB) December 12, 2017
Triangle Insights Group, a premier life sciences strategy consulting firm, announced today that it is expanding its San Francisco operations. The move is driven by the Company’s significant West Coast growth.
The firm has signed a lease taking space in The Mills Building at 220 Montgomery St. This location is the last remaining building reflecting the Chicago School of architecture. The office will feature an open floor-plan that mirrors the culture established at Triangle’s headquarters in Durham, NC.
Kate Kitsopoulos, principal at the firm, stated “[o]ur San Francisco expansion provides closer proximity to a rapidly growing list of West Coast clients; innovators who are developing and commercializing ground-breaking therapeutics, diagnostics, and medical devices.”
This expansion also allows Triangle to further tap the Bay Area’s exceptional talent pool. Chris Apolito, one of the founders of Triangle Insights, commented “as our company grows, we will attract and retain top talent by focusing on graduates from Stanford, UC Berkley and UCLA. Our new emphasis on these schools will augment our strong presence at Duke, UNC, Dartmouth, and UVA.”
Triangle Insight’s senior leadership team will be in San Francisco as a part of the firm’s sponsorship of the Biotech Showcase, which occurs concurrently with the J.P. Morgan Annual Healthcare Conference. These events make San Francisco the center of biotech business activity at the launch of each new year. For the second consecutive year, Triangle Insights will be co-hosting The Distillery reception, an event featuring premiere whiskey tastings, held at the Mezzanine on January 9.
For more information about Triangle Insights Group, visit http://www.triangleinsights.com or call (919) 813-6079.
About Triangle Insights Group
With offices in Research Triangle Park and San Francisco, Triangle Insights Group, LLC is a strategy consulting firm providing guidance on the most critical business issues to leaders in life sciences organizations. The firm’s approach combines deep knowledge of the industry across therapeutic areas and functional groups, with a dedication to creativity and disciplined critical thinking. Recommendations from Triangle Insights Group are original, relevant to the industry environment, and supported by rigorous analytics. Clients of Triangle Insights Group include large pharmaceutical companies, emerging biotechnology firms, diagnostics manufacturers, medical device companies, and private equity investors.